LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 88 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $438,000 | -44.7% | 219,311 | -46.0% | 0.01% | -50.0% |
Q1 2020 | $792,000 | -48.3% | 406,138 | +10.0% | 0.01% | -33.3% |
Q4 2019 | $1,532,000 | -12.9% | 369,243 | -36.8% | 0.02% | -31.8% |
Q3 2019 | $1,759,000 | +186.5% | 584,304 | +498.4% | 0.02% | +175.0% |
Q2 2019 | $614,000 | -34.2% | 97,642 | -41.8% | 0.01% | -38.5% |
Q1 2019 | $933,000 | -43.1% | 167,765 | -32.1% | 0.01% | -55.2% |
Q4 2018 | $1,641,000 | -11.2% | 247,090 | +42.6% | 0.03% | +11.5% |
Q3 2018 | $1,849,000 | -9.9% | 173,330 | +1.3% | 0.03% | -18.8% |
Q2 2018 | $2,053,000 | +167.3% | 171,107 | +90.9% | 0.03% | +146.2% |
Q1 2018 | $768,000 | -46.1% | 89,644 | -37.8% | 0.01% | -48.0% |
Q4 2017 | $1,424,000 | +530.1% | 144,139 | +413.8% | 0.02% | +525.0% |
Q2 2015 | $226,000 | – | 28,054 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |